Works matching IS 00126667 AND DT 2021 AND VI 81 AND IP 16


Results: 13
    1
    2
    3
    4
    5
    6
    7

    Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study.

    Published in:
    2021
    By:
    • Domingo Ribas, Christian;
    • Carrillo Díaz, Teresa;
    • Blanco Aparicio, Marina;
    • Martínez Moragón, Eva;
    • Banas Conejero, David;
    • Sánchez Herrero, M. Guadalupe;
    • the REDES Study Group;
    • Muñoz, Mariana;
    • Cabrerizo, Héctor;
    • Valero, Antonio;
    • Arismendi, Ebymar;
    • Bobolea, Irina;
    • López, Gemma;
    • Pinedo, Celia;
    • González-Barcala, Francisco Javier;
    • Pérez-López-Carona, Purificación;
    • Ramos-González, Jacinto;
    • Martín-Puentes, Javier;
    • Soto-Campos, Gregorio;
    • Pérez-Grimaldi, Francisco
    Publication type:
    Correction Notice
    8

    Difelikefalin: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 16, p. 1937, doi. 10.1007/s40265-021-01619-6
    By:
    • Deeks, Emma D.
    Publication type:
    Article
    9
    10
    11

    Belzutifan: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 16, p. 1921, doi. 10.1007/s40265-021-01606-x
    By:
    • Deeks, Emma D.
    Publication type:
    Article
    12

    Donafenib: First Approval.

    Published in:
    Drugs, 2021, v. 81, n. 16, p. 1915, doi. 10.1007/s40265-021-01603-0
    By:
    • Keam, Susan J.;
    • Duggan, Sean
    Publication type:
    Article
    13